health Post

Leading-Edge Drug Treatments for Hyperkalemia

Hyperkalemia is a serious medical condition that causes accelerated (higher than 6.0 mmol/L) and dangerous levels of potassium within the blood. While a certain level of potassium in the blood is healthy for muscle and nerve function (i.e., for vital organs like the heart), too high potassium chemical levels in the bloodstream is considered detrimental to health and may demand emergency medications or even kidney dialysis to repair. Hyperkalemia is considered a potentially life-threatening condition that can lead to heart arrhythmia, muscle weakness and fatigue, and even paralysis if not treated immediately. Causes of hyperkalemia are most often caused by defective urinary potassium excretion due to under-functioning kidneys, due to chronic kidney disease or acute kidney failure. However, hyperkalemia may also be caused by medications such as beta blockers, potassium supplements, or (ACE) angiotensin-converting enzyme inhibitors; extreme dehydration; type 1 diabetes, or addison’s disease (an adrenal condition). The good news is that several leading-edge hyperkalemia treatments can help: 1. Lokelma Lokelma is a fairly newer sodium zirconium cyclosilicate medication that studies show is able to reduce life-threatening serum K+ levels in hyperkalemia patients within a duration of 48-hours following initial treatment. Lokelma is typically prescribed by doctors to reduce excessive potassium levels in hypokalemia patients in conjunction with RAAS inhibitor therapy in dosages of 10 grams three times daily within a 48-hour timeframe.